Spinal Muscular Atrophy (SMA) is a severe neurodegenerative autosomal recessive disorder. Most of patients are caused by the homozygous absence of a region of exon 7 and exon 8 of the telomeric copy of the SMN gene on chromosome 5. Setting up a molecular diagnostic protocol for detecting SMNt mutation in single cell is basic to Preimplantation Genetic Diagnosis.
Introduction
Spinal Muscular Atrophy (SMA) is a severe neurodegenerative autosomal recessive mutation. SMA is characterized by the progressive degeneration of spinal anterior horn cells lead to muscle weakness symmetrical stem limbs, muscle tone and tendon reflex is lost or reduced, chest deformity and stiffness.
The worldwide incidence of SMA is 1/10,000 live births and the incidence of disease carriers ranges from 1/40 to 1/60 [1] [2] [3] . According to the current international classification, SMA is divided into three categories based on age of disease onset and severity of disease: Severe, intermediate and juvenile form of SMA type I, II, and III. SMN gene including exon 9 encodes the SMN protein molecules 294 amino acids in length. The SMN gene has two copies; SMNt (SMN 1) and SMNc (SMN 2) differ only in 5 base pairs: one in intron 6, one in exon 7, two in exon 7 and one in exon 8. Differences in exon 7 and exon 8 were used to distinguish between SMNt and SMNc in SMA diagnosis ( Figure 1 ).
Differ in one nucleotide of exon 7 between SMNt and SMNc, making SMNt synthesize molecules enough length SMN protein and functional, while protein synthesis by SMNc have very limited functionality.
There are three types of SMN gene mutations that cause SMA disease:
Type 1: Homozygous mutation that lose whole gene SMNt or one part of gene SMNt Type 2: SMNt mutant into SMNc. Type 3: Spot mutation occurred in the SMNt gene of one chromosome, SMNt gene on the remaining chromosome in heterozygous pair 5 mutated into form 1 or 2. Approximately 95% of SMA patients with SMNt mutations are in the form of 1 or 2, only in 5% of SMA patients with SMNt mutations in type 3. Both types 1 and 2 are diagnosed. Predicted by the presence or absence of exon 7 SMNt, this is also the basis of the SMA gene diagnostic method (both type 1 and type 2) [4] [5] [6] [7] [8] [9] [10] [11] .
Treating for these patients creates a burden to both economically and morally for the family and society. Therefore, genetic diagnosis before embryo transfer (Preimplantation Genetic Diagnosis-PGD)
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As the result, we started researching the project:
Establishing assays for detecting SMNt gene mutation in single cell using nested-PCR method.
With target:
Developed a procedure to identify SMNt gene mutations that cause muscular atrophy from a white blood cell separated from the peripheral blood of the patient's family.
Materials and Methods

Research objects
Pick out 4 families with children aged 0 to 18 years to be examined and treated at Vietnam National Children's Hospital, was diagnosed with spinal muscular atrophy due to loss of exon 7 homozygous gene SMNt. 
Results and Discussion
In Figure 2 , exon 7 PCR products were not incubated with DraI (KoDraI) enzyme, and exon 8 was not incubated with DdeI (KoDdeI) enzyme from Patient C3's father (B3), patient C3's mother (M3), C3 patients are the same, with 188 bp-product of exon 7 and 190 bpproduct exon 8.
But when incubated with the enzyme DraI PCR products that:
• B3 and M3 both have 188 bp and 164 bp respectively, meaning both B3 and C3 have exon 7 SMNt (uncuted-188 bp), exon 7 SMNc is cut into two pieces (164 bp and 24 bp).
• Meanwhile the only one C3 has 164 bp -loss homozygous exon 7 SMNt, only exon 7 SMNc was cuted by restriction enzymes into two bands (164 bp, 24 bp). This result is consistent with PCR conclusions from the whole sample of Vietnam National Children's Hospital.
Thus, patients with C3 loss have co-exon 7 and 8 SMNt genes.
This illustrate, we were successful in amplified SMN gene from a human leukemia cells and incubated in step restriction enzymes. However, because of the 2% agarose gel electrophoresis results, the two bands of exon 7 SMNc cuted by the enzyme DraI in sample B3, C3 were not clearly separated.
In Figure 3 , both father (B7) and mother (M7) of the C7 patient have a SMNt exon 7 gene. Therefore, when incubating the PCR products with restriction enzyme DraI have two-stranded (180 bp in exon 7 SMNt and 164 bp in exon 7 SMNc), similar with exon 8 of the SMN gene. Thus, patients also lose C7 exon 7 and exon homozygous gene 8 SMNt.
Conducting research on other patient families, we obtained the following results ( Table 1) 
